1-7 of 7
Roy Eldor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Giuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, Aurora Merovci, Roy Eldor, Devjit Tripathy, Ralph A. DeFronzo, Luke Norton, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2016;39(11):2036–2041
https://doi.org/10.2337/dc15-2688
Published: 25 August 2016
View articletitled, Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Open the PDF for Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes in another window
Journal Articles

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects

Roy Eldor, Giuseppe Daniele, Claudia Huerta, Mariam Al-Atrash, John Adams, Ralph DeFronzo, Timothy Duong, John Lancaster, Mahmoud Zirie, Amin Jayyousi, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2016;39(10):1804–1810
https://doi.org/10.2337/dc15-2706
Published: 03 August 2016
View articletitled, Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects
Open the PDF for Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects in another window
Journal Articles

CD247, a Novel T Cell–Derived Diagnostic and Prognostic Biomarker for Detecting Disease Progression and Severity in Patients With Type 2 Diabetes

Roy Eldor, Yair Klieger, Moshe Sade-Feldman, Ilan Vaknin, Inna Varfolomeev, Camil Fuchs, Michal Baniyash
Journal: Diabetes Care
Diabetes Care 2015;38(1):113–118
https://doi.org/10.2337/dc14-1544
Published: 03 November 2014
View articletitled, CD247, a Novel T Cell–Derived Diagnostic and Prognostic Biomarker for Detecting Disease Progression and Severity in Patients With Type 2 Diabetes
Open the PDF for CD247, a Novel T Cell–Derived Diagnostic and Prognostic Biomarker for Detecting Disease Progression and Severity in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion

Roy Eldor, MD, Ralph A. DeFronzo, MD, Muhammad Abdul-Ghani, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S162–S174
https://doi.org/10.2337/dcS13-2003
Published: 17 July 2013
View articletitled, In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
Open the PDF for In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion in another window
Journal Articles

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

Ralph A. DeFronzo, MD, Roy Eldor, MD, Muhammad Abdul-Ghani, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S127–S138
https://doi.org/10.2337/dcS13-2011
Published: 17 July 2013
View articletitled, Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Open the PDF for Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes in another window
Journal Articles

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?

Roy Eldor, MD, Itamar Raz, MD
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S384–S391
https://doi.org/10.2337/dc09-S345
Published: 01 November 2009
View articletitled, American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Open the PDF for American Diabetes Association Indications for Statins in Diabetes: Is there evidence? in another window
Journal Articles

Lipids and Glucose in Type 2 Diabetes: What About the β-Cell and the Mitochondria?: Response to Boden and Laakso

Roy Eldor, MD, Itamar Raz, MD
Journal: Diabetes Care
Diabetes Care 2005;28(4):985–986
https://doi.org/10.2337/diacare.28.4.985
Published: 01 April 2005
View articletitled, Lipids and Glucose in Type 2 Diabetes: What About the β-Cell and the Mitochondria?: Response to Boden and Laakso
Open the PDF for Lipids and Glucose in Type 2 Diabetes: What About the β-Cell and the Mitochondria?: Response to Boden and Laakso in another window